Certain Ordinary Shares of Mainz Biomed B.V. are subject to a Lock-Up Agreement Ending on 3-MAY-2022. These Ordinary Shares will be under lockup for 180 days starting from 4-NOV-2021 to 3-MAY-2022.

Details:
The officers, directors, and all existing shareholders agree not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any ordinary shares or other securities convertible into or exercisable or exchangeable for ordinary shares for a period of up to 12 months after the date of the underwriting agreement between the Company and the Underwriter without the prior written consent of the Underwriter; provided that those persons who purchased units in April 2021 private placement and August 2021 private placement would be able to: sell one-third of the shares contained in the units that are not registered for resale in the selling shareholder offering and one-third of the shares underlying the warrants contained in such units after 180 days from the initial public offering; sell one-third of the shares contained in the units that are not registered for resale in the selling shareholder offering and one-third of the shares underlying the warrants contained in such units after 270 days from the initial public offering; sell one-third of the shares contained in the units that are not registered for resale in the selling shareholder offering and one-third of the shares underlying the warrants contained in such units after 365 days from the initial public offering; and commencing 90 days after the initial public offering, if ordinary share price is over $7.50 per share for ten consecutive trading days, with at least 100,000 shares traded per day, the such persons may sell one-third of their shares subject to a maximum sale on any trading day of 3% of the daily volume; commencing 90 days after the initial public offering, if ordinary share price is over $10.00 per share for ten consecutive trading days, with at least 100,000 shares traded per day, such persons may sell an additional one-third of their shares subject to a maximum sale on any trading day of 3% of the daily volume; and commencing 90 days after the initial public offering, if ordinary share price is over $15.00 per share for ten consecutive trading days, with at least 100,000 shares traded per day, such persons may sell an additional one-third constituting a maximum total of all of their shares subject to a maximum sale on any trading day of 3% of the daily volume.